Darvadstrocel

CHEMBL4298180 Phase 4 Đã phê duyệt Cell
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

A cell therapy consisting of expanded adipose-derived stem cells used to treat complex perianal fistulas in patients with Crohn's disease. The cells are injected directly into the fistula to promote healing and closure.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

A cell therapy consisting of expanded adipose-derived stem cells used to treat complex perianal fistulas in patients with Crohn's disease. The cells are injected directly into the fistula to promote healing and closure.

Yes, Darvadstrocel is an approved drug. It has reached clinical phase 4. It is classified as a Cell.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4298180. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.